Financhill
Back

Cytokinetics Stock Predictions

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 11.6% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 10 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $38.65. The Score for CYTK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 11.6% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell
20
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 10 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
73.76
52-Week Low:
32.74

Prediction Charts

Market Cap:
4.6B
Price in USD:
38.65
Volume:
2.5M
Beta:
1.45

Technical Analysis

SMA50:
43.89
SMA100:
46.54
SMA200:
50.81
52-Wk Change:
-47.19%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 38.65 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 46.02 44.55 46.07 43.87
Mar-26 44.41 43.63 44.82 42.89
Mar-27 44.07 42.99 44.44 42.68
Mar-28 42.83 43.19 43.33 41.70
Mar-31 42.33 40.19 42.55 39.81
Apr-1 40.28 37.50 41.08 37.46
Apr-2 42.01 40.25 43.69 40.16
Apr-3 39.43 40.52 42.37 39.11
Apr-4 40.44 37.36 40.62 36.89
Apr-7 35.31 35.99 38.08 34.19
Apr-8 36.52 34.57 38.77 34.26
Apr-9 33.67 37.32 38.94 32.74
Apr-10 36.20 37.85 38.42 35.19
Apr-11 37.80 38.65 39.32 36.57

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.46 per share, and an increase next year of $0.70 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.